共 50 条
- [31] Development and evaluation of Hsp90 β-selective inhibitors to overcome the safety challenges associated with pan-Hsp90 inhibitorsCANCER RESEARCH, 2024, 84 (06)Mishra, SanketReynolds, TyelorBlagg, Brian
- [32] Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer stem cellsEUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E670 - U432Tatokoro, M.Koga, F.Yoshida, S.Fukushima, H.Kawakami, S.Fujii, Y.Neckers, L.Kihara, K.
- [33] TSC1 EXPRESSION AS A PREDICTIVE BIOMARKER OF BLADDER CANCER RESPONSE TO HSP90 INHIBITORSJOURNAL OF UROLOGY, 2019, 201 (04): : E45 - E45Hughes, MichaelWoodford, MarkChehab, MahmoudShapiro, OlegBratslavsky, GennadyBourboulia, DimitraMollapour, Mehdi
- [34] Selective inhibition of HSP90 by its C-terminal inhibitors is more effective to suppress bladder cancer cell growthCANCER RESEARCH, 2019, 79 (13)Ling, JunMagura, ConnorSharma, VaibhavRahimi, MaisaraWilliams, Heinric
- [35] The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 InhibitionJOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (03) : 1545 - 1557Mishra, Sanket J.Liu, WeiyaBeebe, KristinBanerjee, MonimoyKent, Caitlin N.Munthali, VitumbikoKoren, John, IIITaylor, John A., IIINeckers, Leonard M.Holzbeierlein, JeffreyBlagg, Brian S. J.
- [36] Recent update on discovery and development of Hsp90 inhibitors as senolytic agentsINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 161 : 1086 - 1098Gupta, Sayan DuttaPan, Cheol Ho
- [37] Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical DevelopmentCURRENT PHARMACEUTICAL DESIGN, 2013, 19 (03) : 366 - 376Soga, ShiroAkinaga, ShiroShiotsu, Yukimasa
- [38] Optical and Radioiodinated Tethered Hsp90 Inhibitors Reveal Selective Internalization of Ectopic Hsp90 in Malignant Breast Tumor CellsCHEMISTRY & BIOLOGY, 2013, 20 (09): : 1187 - 1197Barrott, Jared J.Hughes, Philip F.Osada, TakuyaYang, Xiao-YiHartman, Zachary C.Loiselle, David R.Spector, Neil L.Neckers, LenRajaram, NarasimhanHu, FangyaoRamanujam, NimmiVaidyanathan, GanesanZalutsky, Michael R.Lyerly, H. KimHaystead, Timothy A.
- [39] CLU INHIBITION USING OGX-011 IS A NEW ADJUVANT THERAPEUTIC STRATEGY FOR HSP90 INHIBITION IN PROSTATE CANCERJOURNAL OF UROLOGY, 2011, 185 (04): : E512 - E512Lamoureux, FrancoisYin, Min-JeanZoubeidi, AminaGleave, Martin
- [40] CLU inhibition using OGX-011 is a new adjuvant therapeutic strategy for HSP90 inhibition in prostate cancerCANCER RESEARCH, 2011, 71Lamoureux, FrancoisYin, Min-JeanZoubeidi, AminaGleave, Martin E.